Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

NCT01392989 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Neural Tube Defects
Anemia
Leukemia, Myeloid
Bone Marrow Transplant Failure
Myelodysplastic Syndromes (MDS)
Myeloproliferative Disorders

Interventions

DRUG: CIK cells
DRUG: Cyclosporine
DRUG: Mycophenolate Mofetil
DRUG: Thymoglobulin
RADIATION: Total Lymphoid Irradiation (TLI)

Sponsor

Everett Meyer